Assessment of metabolic syndrome components and body fat distribution in obesity
STEP 1 — Gather Information
Collect BMI, waist circumference (or waist/hip ratio), blood pressure, fasting lipid panel (triglycerides, HDL-C), fasting glucose or HbA1c, current medications, and ethnicity-specific waist cutoffs.
STEP 2 — Rule In / Rule Out
Determine if the patient meets ≥3 of the following MetS criteria: TG ≥150 mg/dL or on TG-lowering medication; HDL-C <50 mg/dL (women) or <40 mg/dL (men); waist circumference ≥102 cm (men) or ≥88 cm (women) (adjust to ≥90 cm for East/South Asian men and ≥80 cm for women); systolic BP ≥130 mm Hg or diastolic ≥85 mm Hg or on antihypertensive medication; prediabetes by fasting glucose 100–125 mg/dL, 2‑h OGTT 140–199 mg/dL, or HbA1c 5.7–6.4%. If ≥3 criteria are present, rule in MetS; otherwise rule out MetS.
STEP 3 — Classify or Stratify
If MetS is present, stratify CVD risk by counting MetS components and noting waist circumference; calculate 10‑year atherosclerotic cardiovascular disease (ASCVD) risk using the Pooled Cohort Equations (requires age, sex, race, total cholesterol, HDL‑C, systolic BP, hypertension treatment, diabetes status, smoking). Classify risk as low (<5%), borderline/intermediate (5–19.9%), or high (≥20%).
STEP 4 — Decide
If 10‑year ASCVD risk ≥20% or ≥7.5% with ≥1 risk‑enhancing factor (including MetS), initiate moderate‑ to high‑intensity statin after risk discussion; if borderline/intermediate risk (5–19.9%) consider coronary artery calcium (CAC) scoring to reclassify risk; if low risk (<5%) reinforce lifestyle measures (diet, exercise, weight loss) and reassess lipids after 5% weight loss.
Clinical Guardrails / Mimics / Pitfalls
Do not rely on BMI alone; waist circumference may be misleading in BMI >35 kg/m²; use ethnic‑specific cutoffs; avoid mislabeling prediabetes; remember that lifestyle‑induced lipid changes do not reduce CVD events; reassess lipid profile after weight loss or bariatric surgery; do not omit hyperglycemia assessment.
Concrete Clinical Example
A 48‑year‑old Hispanic man with BMI 36, waist 100 cm, TG 170 mg/dL, HDL‑C 38 mg/dL, BP 132/84 mm Hg, fasting glucose 108 mg/dL meets 4 MetS criteria; Pooled Cohort Equations give 10‑year ASCVD risk 14%; decision: start moderate‑intensity statin plus lifestyle counseling.
Source: Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2020, doi:10.1210/clinem/dgaa674
TODO: consider adding scripts/calc.py for the endo-mets-assessment-body-fat-distribution-obesity calculator